Medical specialists from India tagged as investigators in clinical trials studying Respiratory Tract Infections

Total 2 results

Ashish Singh
Seen in:
- Tamil Nadu, Vellore, Christian medical college
Trials:
- NCT05083000 (Principal Investigator)
Conditions:
- COVID-19 Respiratory Infection
Subash Babu, MBBS, PhD
Seen in:
- Tamilnadu, Chennai, National Institute for Research in Tuberculosis
Trials:
- NCT04930978 (Principal Investigator)
- NCT04642755 (Principal Investigator)
Conditions:

Clinical Trials on Respiratory Tract Infections

Vakzine Projekt Management GmbH
FGK Clinical Research GmbH

Unknown

Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic

Infection, Respiratory Tract

Germany
GlaxoSmithKline

Completed

A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution

Infections, Respiratory Tract

Germany
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Infections, Respiratory Tract

United States
GlaxoSmithKline

Completed

This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects

Infections, Respiratory Tract

United States
GlaxoSmithKline

Completed

Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses

Infections, Respiratory Tract

Australia
GlaxoSmithKline

Completed

Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study

Infections, Respiratory Tract
GlaxoSmithKline

Completed

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Infections, Respiratory Tract

United States
GlaxoSmithKline

Completed

A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers

Infections, Respiratory Tract

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Infections, Respiratory Syncytial Virus

Canada
GlaxoSmithKline

Completed

Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Infections, Respiratory Syncytial Virus

United States

Medical specialists from India tagged as investigators in clinical trials studying Respiratory Tract Infections

Clinical Trials on Respiratory Tract Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations